1
Enquiry period
with 10.09.2019 15:30
to 11.09.2019 16:00
2
Bidding period
with 11.09.2019 16:00
to 13.09.2019 16:00
3
Auction
16.09.2019 10:37
4
Evaluation
5
Bids have been evaluated
Status Bids have been evaluated
Estimated value without VAT 583,30 MDL
Period of clarifications: 10 Sep 2019, 15:30 - 11 Sep 2019, 16:00
Submission of proposals: 11 Sep 2019, 16:00 - 13 Sep 2019, 16:00
Auction start date: 16 Sep 2019, 10:37

Supplier technical support:

(+373) 79999801

Lot 3. Con de gutaperca 15-40, conţine guta, zinc oxide, bazium sulfata, agent colorant. Cutia: min 120 buc.
Information about customer
Fiscal code/IDNO
Address
MD-2025, MOLDOVA, mun.Chişinău, mun.Chişinău, str. N. Testemiteanu 29
Web site
---
The contact person
Full name
Anastasia Balan
Contact phone
022403697
Purchase data
Date created
10 Sep 2019, 12:58
Date modified
10 Sep 2019, 15:30
Estimated value (without VAT)
583,30 MDL
The minimum downward of the price
5,83 MDL
Achizitii.md ID
21012019
Type of procedure
Low cost purchase
Award criteria
The lowest price
Delivery address
MD-2025, MOLDOVA, mun.Chişinău, mun.Chişinău, str. N. Testemiteanu 29
Contract period
17 Sep 2019 14:56 - 30 Dec 2019 14:59
List of positions
1)
Title
Lot 3. Con de gutaperca 15-40, conţine guta, zinc oxide, bazium sulfata, agent colorant. Cutia: min 120 buc. CPV: 33100000-1 - Medical equipments
Quantity: 10.0
Unit of measurement: Bucata
Documents of the procurement procedure
anunt.de.participare.semnat.pdf anunt.de.participare.semnat.pdf
tenderNotice
anunt de participare
10.09.19 15:30
tabel oferta.xlsx
Technical Specifications
tabel oferta
10.09.19 15:30
Qualification
Participant(s) name(s)
Normalized price
Status
1
Participant(s) name(s):

Visiosystems SRL

Normalized price: 577,50 MDL
Status: Winner
Reason: Cel mai mic preț , corespunde cerințelor solicitate.
Qualification documents
Documents folder missing
Documents provided with the proposal
The history of the auction
View auction
Litigation
File an appeal
К сожалению, вопросы можно задавать только во время периода "Active".
Clarifications